CDHA CAAR

January 27, 2022

CAAR – US National Institutes of Health Funding Opportunities – January 27, 2022

Filed under: Employment/Funding Opportunities — Tags: — admin @ 4:49 pm

A. “Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed),” (PAR-22-058, National Institute on Aging, in conjunction with other agencies, application deadlines March 15, 2022, Aug. 1, 2022, and May 1, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-22-058.html

B. “HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed),” (RFA-DE-22-011, National Institute on Aging, in conjunction with other agencies, application deadline March 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DE-22-011.html

C. “Stimulating Access to Research in Residency (StARR) (R38),” (RFA-HL-23-006, a reissue of of RFA-HL-18-023, National Institute on Aging, in conjunction with other agencides, application deadlines March 15, 2022, March 15, 2023, and March 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-006.html

D. “BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed),” (RFA-MH-22-145, a reissue of RFA-MH-20-128, National Institute on Aging, in conjunction with other agencies, application deadlines June 14, 2022, June 14, 2023, and June 14, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-145.html

E. “Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional),” (RFA-MH-22-175, a reissue of RFA-MH-21-145, application deadline March 18, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Emergency Award HEAL Initiative: Developing and Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional),” (RFA-MH-22-176).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-175.html

F. “HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required),” (RFA-NS-22-037, National Institute on Aging, in conjunction with other agencies, application deadlines March 22, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-037.html

G. “Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed),” (RFA-TR-22-011, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 28, 2022, Aug. 22, 2022, and May 23, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-012.html

H. “Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed),” (RFA-TR-22-012, National Institute on Aging, in conjunction with other agencies, application deadline March 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-012.html

I. “Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed),” (RFA-TR-22-013, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 28, 2022, Aug. 22, 2022, and May 22, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-TR-22-013.html

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress